查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1977635

2026-2034年全球人工胰臟裝置系統（APDS）市場規模、佔有率、趨勢和成長分析報告

Global Artificial Pancreas Device Systems (APDS) Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 113 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

人工胰臟裝置系統 (APDS) 市場預計將從 2025 年的 9.9 億美元成長到 2034 年的 21.9 億美元，2026 年至 2034 年的複合年成長率為 9.19%。

全球人工胰臟裝置系統（APDS）市場正經歷強勁成長，這主要得益於全球糖尿病患者數量的不斷增加。人們對先進糖尿病管理解決方案的認知度不斷提高，以及對持續血糖監測需求的日益成長，推動了該技術的普及應用。胰島素幫浦、持續血糖監測儀和控制演算法的整合等技術進步，提高了治療的精確度。已開發地區醫療費用支出的成長和有利的報銷政策，也進一步促進了市場擴張。

關鍵成長要素包括老年人口的成長以及1型和2型糖尿病患者數量的增加。胰島素自動輸注封閉回路型系統的持續創新正在提高患者的便利性和血糖控制水平。醫療設備製造商與數位健康公司之間的合作正在加速產品開發。此外，患者對微創和穿戴式解決方案的日益青睞也增強了醫院和居家醫療機構的需求。

未來，人工智慧的融合和感測器精度的提升可望推動市場發展。新興國家醫療基礎設施的擴建也將創造新的成長機會。各公司正致力於降低成本和產品小型化，以提高產品的可及性。隨著個人化醫療和遠端監測的日益普及，全球人工胰臟裝置系統（APDS）市場預計將保持長期持續成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章 全球人工胰臟裝置系統（APDS）市場：依裝置類型分類

  • 市場分析、洞察與預測
  • 閾值停止裝置系統
  • 控制範圍（CTR）系統
  • 目標值控制系統（CTT）

第5章 全球人工胰臟裝置系統（APDS）市場：依最終使用者分類

  • 市場分析、洞察與預測
  • 醫院
  • 診所
  • 居家照護

第6章 全球人工胰臟裝置系統（APDS）市場：依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第7章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第8章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Medtronic Plc
    • Bigfoot Biomedical Inc
    • Pancreum Inc
    • Johnson & Johnson
    • Beta Bionics Inc
    • TypeZero Technologies LLC
    • Insulet Corporation
    • Diabeloop
    • Tandem Diabetes Care Inc
    • Inreda Diabetic
簡介目錄
Product Code: VMR112112598

The Artificial Pancreas Device Systems (APDS) Market size is expected to reach USD 2.19 Billion in 2034 from USD 0.99 Billion (2025) growing at a CAGR of 9.19% during 2026-2034.

The Global Artificial Pancreas Device Systems (APDS) Market is witnessing robust growth due to the rising prevalence of diabetes worldwide. Increasing awareness about advanced diabetes management solutions and the need for continuous glucose monitoring are driving adoption. Technological advancements integrating insulin pumps, continuous glucose monitors, and control algorithms have improved treatment accuracy. Growing healthcare expenditure and favorable reimbursement policies in developed regions are further supporting market expansion.

Key growth drivers include the rising geriatric population and increasing cases of Type 1 and Type 2 diabetes. Continuous innovations in closed-loop systems that automate insulin delivery are enhancing patient convenience and glycemic control. Collaboration between medical device manufacturers and digital health companies is accelerating product development. Additionally, growing patient preference for minimally invasive and wearable solutions is strengthening demand across hospitals and homecare settings.

In the future, the market is expected to benefit from artificial intelligence integration and improved sensor accuracy. Expanding healthcare infrastructure in emerging economies will create new growth opportunities. Companies are focusing on cost reduction and product miniaturization to improve accessibility. As personalized medicine and remote monitoring gain traction, the Global Artificial Pancreas Device Systems (APDS) Market is projected to experience sustained long-term growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Device Type

  • Threshold Suspend Device Systems
  • Control-To-Range (CTR) Systems
  • Control-To-Target (CTT) Systems

By End User

  • Hospitals
  • Clinics
  • Homecare

COMPANIES PROFILED

  • Medtronic plc, Bigfoot Biomedical Inc, Pancreum Inc, Johnson Johnson, Beta Bionics Inc, TypeZero Technologies LLC, Insulet Corporation, Diabeloop, Tandem Diabetes Care Inc, Inreda Diabetic
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEMS (APDS) MARKET: BY DEVICE TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Device Type
  • 4.2. Threshold Suspend Device Systems Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Control-To-Range (CTR) Systems Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Control-To-Target (CTT) Systems Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEMS (APDS) MARKET: BY END USER 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast End User
  • 5.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Homecare Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEMS (APDS) MARKET: BY REGION 2022-2034(USD MN)

  • 6.1. Regional Outlook
  • 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.2.1 By Device Type
    • 6.2.2 By End User
    • 6.2.3 United States
    • 6.2.4 Canada
    • 6.2.5 Mexico
  • 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.3.1 By Device Type
    • 6.3.2 By End User
    • 6.3.3 United Kingdom
    • 6.3.4 France
    • 6.3.5 Germany
    • 6.3.6 Italy
    • 6.3.7 Russia
    • 6.3.8 Rest Of Europe
  • 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.4.1 By Device Type
    • 6.4.2 By End User
    • 6.4.3 India
    • 6.4.4 Japan
    • 6.4.5 South Korea
    • 6.4.6 Australia
    • 6.4.7 South East Asia
    • 6.4.8 Rest Of Asia Pacific
  • 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.5.1 By Device Type
    • 6.5.2 By End User
    • 6.5.3 Brazil
    • 6.5.4 Argentina
    • 6.5.5 Peru
    • 6.5.6 Chile
    • 6.5.7 South East Asia
    • 6.5.8 Rest of Latin America
  • 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.6.1 By Device Type
    • 6.6.2 By End User
    • 6.6.3 Saudi Arabia
    • 6.6.4 UAE
    • 6.6.5 Israel
    • 6.6.6 South Africa
    • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

  • 7.1. Recent Developments
  • 7.2. Company Categorization
  • 7.3. Supply Chain & Channel Partners (based on availability)
  • 7.4. Market Share & Positioning Analysis (based on availability)
  • 7.5. Vendor Landscape (based on availability)
  • 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEMS (APDS) INDUSTRY

  • 8.1. Top Companies Market Share Analysis
  • 8.2. Company Profiles
    • 8.2.1 Medtronic Plc
    • 8.2.2 Bigfoot Biomedical Inc
    • 8.2.3 Pancreum Inc
    • 8.2.4 Johnson & Johnson
    • 8.2.5 Beta Bionics Inc
    • 8.2.6 TypeZero Technologies LLC
    • 8.2.7 Insulet Corporation
    • 8.2.8 Diabeloop
    • 8.2.9 Tandem Diabetes Care Inc
    • 8.2.10 Inreda Diabetic